

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to interleukin-15 (GO:0071350) | 7.86329152 |
| 2 | * negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.08140919 |
| 3 | * negative regulation of cell killing (GO:0031342) | 7.08140919 |
| 4 | response to interleukin-15 (GO:0070672) | 6.97388503 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.22063936 |
| 6 | interferon-gamma production (GO:0032609) | 5.77765392 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.42889139 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.15703141 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.03775394 |
| 10 | negative thymic T cell selection (GO:0045060) | 5.01683528 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.98565495 |
| 12 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.81594771 |
| 13 | negative T cell selection (GO:0043383) | 4.81090238 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.79223725 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.77206780 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.69474212 |
| 17 | regulation of memory T cell differentiation (GO:0043380) | 4.66769647 |
| 18 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.63917776 |
| 19 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.61890234 |
| 20 | negative regulation of T-helper cell differentiation (GO:0045623) | 4.50867885 |
| 21 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 4.50867885 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 4.48900290 |
| 23 | sleep (GO:0030431) | 4.44943090 |
| 24 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 4.37880815 |
| 25 | tolerance induction (GO:0002507) | 4.34522363 |
| 26 | mast cell activation (GO:0045576) | 4.33190136 |
| 27 | * regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.30038039 |
| 28 | negative regulation of T cell mediated immunity (GO:0002710) | 4.24017306 |
| 29 | neutrophil activation involved in immune response (GO:0002283) | 4.18517044 |
| 30 | * regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.14966854 |
| 31 | * regulation of natural killer cell mediated immunity (GO:0002715) | 4.14966854 |
| 32 | activated T cell proliferation (GO:0050798) | 4.09992807 |
| 33 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.07472539 |
| 34 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 4.03890004 |
| 35 | natural killer cell activation (GO:0030101) | 3.95537955 |
| 36 | * regulation of cell killing (GO:0031341) | 3.94269118 |
| 37 | positive regulation of T cell cytokine production (GO:0002726) | 3.91061551 |
| 38 | * positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.79910126 |
| 39 | leukocyte aggregation (GO:0070486) | 3.79382012 |
| 40 | regulation of regulatory T cell differentiation (GO:0045589) | 3.76655114 |
| 41 | cellular defense response (GO:0006968) | 3.75490282 |
| 42 | neutrophil activation (GO:0042119) | 3.72152349 |
| 43 | * negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.68923991 |
| 44 | positive regulation of T cell mediated immunity (GO:0002711) | 3.66309114 |
| 45 | response to muramyl dipeptide (GO:0032495) | 3.59992066 |
| 46 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.59167948 |
| 47 | regulation of T cell mediated immunity (GO:0002709) | 3.55352523 |
| 48 | natural killer cell differentiation (GO:0001779) | 3.53089276 |
| 49 | regulation of germinal center formation (GO:0002634) | 3.53001251 |
| 50 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 3.47028972 |
| 51 | positive thymic T cell selection (GO:0045059) | 3.46100015 |
| 52 | * positive regulation of cell killing (GO:0031343) | 3.46036484 |
| 53 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.45177858 |
| 54 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.43912212 |
| 55 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.40858486 |
| 56 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.37705758 |
| 57 | mast cell degranulation (GO:0043303) | 3.37616249 |
| 58 | mast cell activation involved in immune response (GO:0002279) | 3.37616249 |
| 59 | * negative regulation of leukocyte mediated immunity (GO:0002704) | 3.36824279 |
| 60 | thymic T cell selection (GO:0045061) | 3.35904367 |
| 61 | regulation of T-helper 1 type immune response (GO:0002825) | 3.29401549 |
| 62 | granulocyte activation (GO:0036230) | 3.28854723 |
| 63 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.27656710 |
| 64 | regulation of hypersensitivity (GO:0002883) | 3.27128688 |
| 65 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 3.25943323 |
| 66 | leukocyte degranulation (GO:0043299) | 3.25718314 |
| 67 | dendritic cell chemotaxis (GO:0002407) | 3.21156077 |
| 68 | cellular extravasation (GO:0045123) | 3.20728710 |
| 69 | lymph node development (GO:0048535) | 3.17410244 |
| 70 | regulation of activation of Janus kinase activity (GO:0010533) | 3.13918224 |
| 71 | positive regulation of defense response to virus by host (GO:0002230) | 3.11705436 |
| 72 | T cell selection (GO:0045058) | 3.07625355 |
| 73 | T cell migration (GO:0072678) | 3.07619869 |
| 74 | * positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.06829560 |
| 75 | negative regulation of adaptive immune response (GO:0002820) | 3.02883819 |
| 76 | positive regulation of mast cell activation (GO:0033005) | 3.01544960 |
| 77 | positive regulation of interleukin-17 production (GO:0032740) | 3.00784743 |
| 78 | T cell proliferation (GO:0042098) | 3.00251477 |
| 79 | positive regulation of osteoclast differentiation (GO:0045672) | 2.99476028 |
| 80 | negative regulation of T cell apoptotic process (GO:0070233) | 2.98920384 |
| 81 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.96502729 |
| 82 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.96084086 |
| 83 | positive regulation of heat generation (GO:0031652) | 2.95809836 |
| 84 | * regulation of lymphocyte mediated immunity (GO:0002706) | 2.95554705 |
| 85 | positive regulation of prostaglandin secretion (GO:0032308) | 2.95427756 |
| 86 | regulation of mast cell activation (GO:0033003) | 2.93055481 |
| 87 | rRNA catabolic process (GO:0016075) | 2.91028456 |
| 88 | cellular response to prostaglandin stimulus (GO:0071379) | 2.90425496 |
| 89 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.89698645 |
| 90 | * positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.86359826 |
| 91 | myeloid cell activation involved in immune response (GO:0002275) | 2.86322668 |
| 92 | positive regulation of macrophage differentiation (GO:0045651) | 2.85659727 |
| 93 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.84442600 |
| 94 | regulation of T cell cytokine production (GO:0002724) | 2.84426223 |
| 95 | Peyers patch development (GO:0048541) | 2.82814830 |
| 96 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.82814830 |
| 97 | * negative regulation of innate immune response (GO:0045824) | 2.81177465 |
| 98 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.80921157 |
| 99 | DNA deamination (GO:0045006) | 2.80848374 |
| 100 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.80410559 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.83880276 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.32981321 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.30195914 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.30885549 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.63617438 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.38486285 |
| 7 | MYB_26560356_Chip-Seq_TH2_Human | 2.94295958 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.75988261 |
| 9 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.73892677 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73562426 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.72294443 |
| 12 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.68874420 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.62382617 |
| 14 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.51739157 |
| 15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.42377868 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.36562304 |
| 17 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.26993764 |
| 18 | GATA3_26560356_Chip-Seq_TH2_Human | 2.24872998 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.20156157 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.19408556 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 2.12726553 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.09783454 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06653397 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.03644537 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 2.02609628 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.99907684 |
| 27 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.87952229 |
| 28 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83856253 |
| 29 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.83488359 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82800009 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.81097807 |
| 32 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.68212888 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60988690 |
| 34 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.59054305 |
| 35 | MAF_26560356_Chip-Seq_TH2_Human | 1.54263340 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.51751134 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.45690417 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41030661 |
| 39 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.40730999 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39664162 |
| 41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.39303119 |
| 42 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36320101 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.27478871 |
| 44 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.26962062 |
| 45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.25128578 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25109118 |
| 47 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23883524 |
| 48 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.22620981 |
| 49 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17609518 |
| 50 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16471551 |
| 51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14222029 |
| 52 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14027551 |
| 53 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13551439 |
| 54 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12508328 |
| 55 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12369072 |
| 56 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.12124686 |
| 57 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08835757 |
| 58 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.08642875 |
| 59 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08421191 |
| 60 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.08150739 |
| 61 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.07440370 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06350078 |
| 63 | P300_27268052_Chip-Seq_Bcells_Human | 1.06177690 |
| 64 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06099320 |
| 65 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05270610 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02348865 |
| 67 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00382801 |
| 68 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99452814 |
| 69 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98672099 |
| 70 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94688972 |
| 71 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.93964065 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92153313 |
| 73 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.92096171 |
| 74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.91997449 |
| 75 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91643517 |
| 76 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.91034677 |
| 77 | GATA3_26560356_Chip-Seq_TH1_Human | 0.90322421 |
| 78 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.90237254 |
| 79 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90171897 |
| 80 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.89724190 |
| 81 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.89091211 |
| 82 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88305413 |
| 83 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.87262349 |
| 84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86024607 |
| 85 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.85337379 |
| 86 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.85182452 |
| 87 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.83261568 |
| 88 | SA1_27219007_Chip-Seq_Bcells_Human | 0.82842960 |
| 89 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.82309123 |
| 90 | GATA1_22025678_ChIP-Seq_K562_Human | 0.80984498 |
| 91 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79403637 |
| 92 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.78790574 |
| 93 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77357214 |
| 94 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.77216350 |
| 95 | AR_20517297_ChIP-Seq_VCAP_Human | 0.77007203 |
| 96 | MYC_22102868_ChIP-Seq_BL_Human | 0.76631353 |
| 97 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.76587536 |
| 98 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.75352403 |
| 99 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.74739184 |
| 100 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74618745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.33171002 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.32871525 |
| 3 | MP0003724_increased_susceptibility_to | 4.23066606 |
| 4 | MP0003436_decreased_susceptibility_to | 3.65284199 |
| 5 | MP0000685_abnormal_immune_system | 3.53237765 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.25256913 |
| 7 | MP0003763_abnormal_thymus_physiology | 3.15156385 |
| 8 | MP0001800_abnormal_humoral_immune | 2.93863966 |
| 9 | MP0006082_CNS_inflammation | 2.90117186 |
| 10 | MP0002723_abnormal_immune_serum | 2.75014837 |
| 11 | MP0001790_abnormal_immune_system | 2.67966884 |
| 12 | MP0005387_immune_system_phenotype | 2.67966884 |
| 13 | MP0005025_abnormal_response_to | 2.64353844 |
| 14 | MP0005075_abnormal_melanosome_morpholog | 2.60163190 |
| 15 | MP0001819_abnormal_immune_cell | 2.58995531 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.58691880 |
| 17 | MP0009785_altered_susceptibility_to | 2.55739570 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.54654523 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.43118480 |
| 20 | MP0002419_abnormal_innate_immunity | 2.34074228 |
| 21 | MP0003878_abnormal_ear_physiology | 2.16192330 |
| 22 | MP0005377_hearing/vestibular/ear_phenot | 2.16192330 |
| 23 | MP0000465_gastrointestinal_hemorrhage | 2.13124147 |
| 24 | MP0002398_abnormal_bone_marrow | 2.07682464 |
| 25 | MP0002405_respiratory_system_inflammati | 2.03863771 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.00771751 |
| 27 | MP0000703_abnormal_thymus_morphology | 1.99509800 |
| 28 | MP0000716_abnormal_immune_system | 1.99131624 |
| 29 | MP0004043_abnormal_pH_regulation | 1.97921351 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.94486578 |
| 31 | MP0004947_skin_inflammation | 1.94049620 |
| 32 | MP0002722_abnormal_immune_system | 1.90180001 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.85731776 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.68523118 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.61631911 |
| 36 | MP0003866_abnormal_defecation | 1.54898405 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.53069448 |
| 38 | MP0008877_abnormal_DNA_methylation | 1.52677244 |
| 39 | MP0002429_abnormal_blood_cell | 1.52086643 |
| 40 | MP0001348_abnormal_lacrimal_gland | 1.44243958 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.40735830 |
| 42 | MP0002876_abnormal_thyroid_physiology | 1.39031601 |
| 43 | MP0004130_abnormal_muscle_cell | 1.33805922 |
| 44 | MP0005310_abnormal_salivary_gland | 1.31819195 |
| 45 | MP0009764_decreased_sensitivity_to | 1.30971885 |
| 46 | MP0004381_abnormal_hair_follicle | 1.22233633 |
| 47 | MP0008469_abnormal_protein_level | 1.21336996 |
| 48 | MP0003828_pulmonary_edema | 1.18341121 |
| 49 | MP0003252_abnormal_bile_duct | 1.18188777 |
| 50 | MP0004147_increased_porphyrin_level | 1.14958024 |
| 51 | MP0001851_eye_inflammation | 1.13391494 |
| 52 | MP0002933_joint_inflammation | 1.12718036 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.11513253 |
| 54 | MP0002163_abnormal_gland_morphology | 1.10931959 |
| 55 | MP0002006_tumorigenesis | 1.10856607 |
| 56 | MP0003195_calcinosis | 1.08321331 |
| 57 | MP0004142_abnormal_muscle_tone | 1.04270520 |
| 58 | MP0003787_abnormal_imprinting | 1.03560888 |
| 59 | MP0000015_abnormal_ear_pigmentation | 1.02704199 |
| 60 | MP0000858_altered_metastatic_potential | 1.01287399 |
| 61 | MP0001873_stomach_inflammation | 0.97378169 |
| 62 | MP0002998_abnormal_bone_remodeling | 0.97180282 |
| 63 | MP0001501_abnormal_sleep_pattern | 0.92646735 |
| 64 | MP0003879_abnormal_hair_cell | 0.92351376 |
| 65 | MP0006054_spinal_hemorrhage | 0.90710600 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 0.88405570 |
| 67 | MP0009763_increased_sensitivity_to | 0.86014134 |
| 68 | MP0008872_abnormal_physiological_respon | 0.85676496 |
| 69 | MP0005390_skeleton_phenotype | 0.82657076 |
| 70 | MP0005174_abnormal_tail_pigmentation | 0.80067691 |
| 71 | MP0003303_peritoneal_inflammation | 0.79273277 |
| 72 | MP0003638_abnormal_response/metabolism_ | 0.76539821 |
| 73 | MP0001853_heart_inflammation | 0.75829936 |
| 74 | MP0003172_abnormal_lysosome_physiology | 0.75795468 |
| 75 | MP0008873_increased_physiological_sensi | 0.73850765 |
| 76 | MP0001765_abnormal_ion_homeostasis | 0.72871862 |
| 77 | MP0005083_abnormal_biliary_tract | 0.72718388 |
| 78 | MP0003045_fibrosis | 0.72714399 |
| 79 | MP0004885_abnormal_endolymph | 0.72708233 |
| 80 | MP0002019_abnormal_tumor_incidence | 0.72546284 |
| 81 | MP0003448_altered_tumor_morphology | 0.68292228 |
| 82 | MP0005379_endocrine/exocrine_gland_phen | 0.68088967 |
| 83 | MP0005084_abnormal_gallbladder_morpholo | 0.67972035 |
| 84 | MP0002009_preneoplasia | 0.63975726 |
| 85 | MP0003011_delayed_dark_adaptation | 0.61537698 |
| 86 | MP0002102_abnormal_ear_morphology | 0.60204742 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.59996266 |
| 88 | MP0001346_abnormal_lacrimal_gland | 0.59979930 |
| 89 | MP0010307_abnormal_tumor_latency | 0.59933982 |
| 90 | MP0010329_abnormal_lipoprotein_level | 0.57959929 |
| 91 | MP0001919_abnormal_reproductive_system | 0.57246017 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.55835778 |
| 93 | MP0003795_abnormal_bone_structure | 0.53191814 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.52217080 |
| 95 | MP0005360_urolithiasis | 0.52051327 |
| 96 | MP0002132_abnormal_respiratory_system | 0.51772912 |
| 97 | MP0004145_abnormal_muscle_electrophysio | 0.50222584 |
| 98 | MP0000249_abnormal_blood_vessel | 0.49259133 |
| 99 | MP0003690_abnormal_glial_cell | 0.49019616 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 0.48853230 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgG deficiency (HP:0004315) | 5.55819855 |
| 2 | Myositis (HP:0100614) | 5.53923623 |
| 3 | T lymphocytopenia (HP:0005403) | 5.37408374 |
| 4 | Abnormality of T cell number (HP:0011839) | 5.35378877 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 5.28655534 |
| 6 | Optic neuritis (HP:0100653) | 5.28655534 |
| 7 | Orchitis (HP:0100796) | 4.92137230 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.53306147 |
| 9 | Abnormality of T cells (HP:0002843) | 4.42393904 |
| 10 | Severe combined immunodeficiency (HP:0004430) | 4.31484014 |
| 11 | Encephalitis (HP:0002383) | 4.19977813 |
| 12 | Abnormality of eosinophils (HP:0001879) | 4.03790465 |
| 13 | Stomatitis (HP:0010280) | 3.85804195 |
| 14 | Pustule (HP:0200039) | 3.82161082 |
| 15 | Keratoconjunctivitis (HP:0001096) | 3.77107240 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.70267770 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 3.67847873 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.67847873 |
| 19 | Premature loss of primary teeth (HP:0006323) | 3.59427734 |
| 20 | Abnormality of T cell physiology (HP:0011840) | 3.55467291 |
| 21 | Combined immunodeficiency (HP:0005387) | 3.42670298 |
| 22 | Keratoconjunctivitis sicca (HP:0001097) | 3.41361209 |
| 23 | Hemiplegia (HP:0002301) | 3.36654404 |
| 24 | Panhypogammaglobulinemia (HP:0003139) | 3.24251759 |
| 25 | Recurrent fungal infections (HP:0002841) | 3.22425785 |
| 26 | Hypoproteinemia (HP:0003075) | 3.22306430 |
| 27 | Recurrent bacterial skin infections (HP:0005406) | 3.19064685 |
| 28 | Renal cortical cysts (HP:0000803) | 3.18883921 |
| 29 | Pulmonary infiltrates (HP:0002113) | 3.18034596 |
| 30 | Meningitis (HP:0001287) | 3.17108208 |
| 31 | Recurrent bronchitis (HP:0002837) | 3.16098998 |
| 32 | Leukocytosis (HP:0001974) | 3.13025944 |
| 33 | Eosinophilia (HP:0001880) | 3.09927214 |
| 34 | Joint swelling (HP:0001386) | 3.07925270 |
| 35 | Recurrent abscess formation (HP:0002722) | 3.06990976 |
| 36 | Persistence of primary teeth (HP:0006335) | 2.96456488 |
| 37 | Increased density of long bones (HP:0006392) | 2.92064355 |
| 38 | Increased IgM level (HP:0003496) | 2.92028783 |
| 39 | Alveolar cell carcinoma (HP:0006519) | 2.91557135 |
| 40 | Eczematoid dermatitis (HP:0000976) | 2.89131608 |
| 41 | Thyroiditis (HP:0100646) | 2.84451900 |
| 42 | Vasculitis (HP:0002633) | 2.83521179 |
| 43 | Granulocytopenia (HP:0001913) | 2.81288822 |
| 44 | Abnormality of macrophages (HP:0004311) | 2.77784692 |
| 45 | Hemoptysis (HP:0002105) | 2.77017714 |
| 46 | Arterial thrombosis (HP:0004420) | 2.71459509 |
| 47 | Stomach cancer (HP:0012126) | 2.70394038 |
| 48 | Recurrent skin infections (HP:0001581) | 2.68132152 |
| 49 | Clumsiness (HP:0002312) | 2.67218547 |
| 50 | Gastrointestinal infarctions (HP:0005244) | 2.65177216 |
| 51 | Amyotrophic lateral sclerosis (HP:0007354) | 2.63080105 |
| 52 | Abnormality of B cell number (HP:0010975) | 2.59616446 |
| 53 | Conical tooth (HP:0000698) | 2.56978627 |
| 54 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.53828440 |
| 55 | IgM deficiency (HP:0002850) | 2.50096632 |
| 56 | Keratitis (HP:0000491) | 2.46767448 |
| 57 | Anorexia (HP:0002039) | 2.44720494 |
| 58 | Facial diplegia (HP:0001349) | 2.28575594 |
| 59 | B lymphocytopenia (HP:0010976) | 2.26295939 |
| 60 | Dysostosis multiplex (HP:0000943) | 2.23928946 |
| 61 | Mediastinal lymphadenopathy (HP:0100721) | 2.23112644 |
| 62 | Petechiae (HP:0000967) | 2.21925931 |
| 63 | Pulmonary embolism (HP:0002204) | 2.21355462 |
| 64 | Anhidrosis (HP:0000970) | 2.21219168 |
| 65 | Abnormality of glycolipid metabolism (HP:0010969) | 2.20391558 |
| 66 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.20391558 |
| 67 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.20391558 |
| 68 | Prolonged bleeding time (HP:0003010) | 2.16708387 |
| 69 | Vertigo (HP:0002321) | 2.15873868 |
| 70 | Gangrene (HP:0100758) | 2.15550376 |
| 71 | Abnormality of the renal cortex (HP:0011035) | 2.15184568 |
| 72 | Hypochromic anemia (HP:0001931) | 2.14788177 |
| 73 | Chest pain (HP:0100749) | 2.13163024 |
| 74 | Inflammation of the large intestine (HP:0002037) | 2.13082295 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.11265848 |
| 76 | Hypoplasia of the thymus (HP:0000778) | 2.08203255 |
| 77 | Cutaneous melanoma (HP:0012056) | 2.07966164 |
| 78 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07217237 |
| 79 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07217237 |
| 80 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07217237 |
| 81 | Bronchitis (HP:0012387) | 2.06180796 |
| 82 | Gingival bleeding (HP:0000225) | 2.04287484 |
| 83 | Abnormality of the endocardium (HP:0004306) | 2.03862979 |
| 84 | Autoimmune thrombocytopenia (HP:0001973) | 2.03263612 |
| 85 | Gastrointestinal inflammation (HP:0004386) | 1.92127520 |
| 86 | Epistaxis (HP:0000421) | 1.91928912 |
| 87 | Arthralgia (HP:0002829) | 1.91345985 |
| 88 | Adactyly (HP:0009776) | 1.90908293 |
| 89 | Spontaneous hematomas (HP:0007420) | 1.89985201 |
| 90 | Visual hallucinations (HP:0002367) | 1.82868260 |
| 91 | Abnormality of the radial head (HP:0003995) | 1.82499710 |
| 92 | Dislocated radial head (HP:0003083) | 1.81970254 |
| 93 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.81176889 |
| 94 | Increased CSF protein (HP:0002922) | 1.79224619 |
| 95 | Polyneuropathy (HP:0001271) | 1.78013765 |
| 96 | Agitation (HP:0000713) | 1.77361358 |
| 97 | Attenuation of retinal blood vessels (HP:0007843) | 1.77145721 |
| 98 | Brittle hair (HP:0002299) | 1.76580731 |
| 99 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.76485116 |
| 100 | Mucopolysacchariduria (HP:0008155) | 1.76485116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 7.07682838 |
| 2 | MAP3K14 | 3.95019482 |
| 3 | GRK6 | 3.85871440 |
| 4 | MAP4K1 | 3.32043225 |
| 5 | BMPR2 | 3.16576159 |
| 6 | FES | 3.02807435 |
| 7 | TAOK3 | 2.85570540 |
| 8 | MAP4K2 | 2.55454374 |
| 9 | TESK2 | 2.54127058 |
| 10 | MAP2K2 | 2.42557670 |
| 11 | JAK1 | 2.31634715 |
| 12 | JAK3 | 2.12806902 |
| 13 | IKBKE | 2.09583193 |
| 14 | TLK1 | 2.06863821 |
| 15 | IKBKB | 1.94952565 |
| 16 | RIPK4 | 1.93415263 |
| 17 | TBK1 | 1.86552062 |
| 18 | BTK | 1.83216459 |
| 19 | MUSK | 1.73115611 |
| 20 | TNK2 | 1.59860172 |
| 21 | MARK3 | 1.51102745 |
| 22 | SYK | 1.49900421 |
| 23 | ZAP70 | 1.48937365 |
| 24 | LCK | 1.48709175 |
| 25 | ACVR1B | 1.44086293 |
| 26 | CSK | 1.42998930 |
| 27 | ITK | 1.41931030 |
| 28 | KIT | 1.35253264 |
| 29 | SIK2 | 1.32989274 |
| 30 | MAP3K13 | 1.28177003 |
| 31 | LYN | 1.25891100 |
| 32 | HCK | 1.24891488 |
| 33 | KDR | 1.21869772 |
| 34 | SIK3 | 1.21211621 |
| 35 | NUAK1 | 1.20771604 |
| 36 | TYK2 | 1.12319386 |
| 37 | TEC | 1.08737120 |
| 38 | ADRBK2 | 1.07511133 |
| 39 | CSF1R | 1.06326552 |
| 40 | MATK | 1.04467909 |
| 41 | CAMKK2 | 1.00194545 |
| 42 | IRAK4 | 0.97329570 |
| 43 | PIM1 | 0.96997521 |
| 44 | BLK | 0.95856401 |
| 45 | PRKCQ | 0.94163943 |
| 46 | CDK3 | 0.93889123 |
| 47 | LIMK1 | 0.83407591 |
| 48 | ERN1 | 0.82841558 |
| 49 | ZAK | 0.81906744 |
| 50 | FGR | 0.71911613 |
| 51 | PIK3CG | 0.70766638 |
| 52 | STK10 | 0.67968925 |
| 53 | CAMKK1 | 0.66667500 |
| 54 | CDK4 | 0.66389146 |
| 55 | GRK1 | 0.66157933 |
| 56 | GRK7 | 0.62800968 |
| 57 | WNK4 | 0.62784344 |
| 58 | MAP3K4 | 0.59495528 |
| 59 | EIF2AK2 | 0.59308143 |
| 60 | PDK1 | 0.59104688 |
| 61 | IGF1R | 0.56991713 |
| 62 | CHUK | 0.55063546 |
| 63 | MAPK7 | 0.50323288 |
| 64 | PRKCH | 0.50098263 |
| 65 | RAF1 | 0.47846055 |
| 66 | NEK6 | 0.47071778 |
| 67 | FYN | 0.43469749 |
| 68 | MAP2K1 | 0.43158444 |
| 69 | JAK2 | 0.42352260 |
| 70 | MAPKAPK2 | 0.41489522 |
| 71 | MAPK11 | 0.41319724 |
| 72 | ABL1 | 0.39760022 |
| 73 | FRK | 0.38441002 |
| 74 | MAPK12 | 0.37178488 |
| 75 | MAPK13 | 0.36869969 |
| 76 | INSR | 0.33624701 |
| 77 | BCKDK | 0.33194853 |
| 78 | CDC42BPA | 0.33072516 |
| 79 | MAP2K6 | 0.32928762 |
| 80 | KSR2 | 0.31308397 |
| 81 | STK11 | 0.29490588 |
| 82 | MAPKAPK3 | 0.28525137 |
| 83 | TGFBR2 | 0.26177083 |
| 84 | RPS6KA2 | 0.22912049 |
| 85 | MOS | 0.22822538 |
| 86 | BCR | 0.22501724 |
| 87 | EPHB1 | 0.22499848 |
| 88 | NME1 | 0.22442640 |
| 89 | PRKCD | 0.20475696 |
| 90 | EGFR | 0.20367868 |
| 91 | BRD4 | 0.18628554 |
| 92 | ADRBK1 | 0.18555386 |
| 93 | OXSR1 | 0.17179063 |
| 94 | KSR1 | 0.15795268 |
| 95 | MAP2K3 | 0.15714443 |
| 96 | PTK2B | 0.15456824 |
| 97 | PINK1 | 0.12284322 |
| 98 | PTK6 | 0.12160878 |
| 99 | GRK5 | 0.12000266 |
| 100 | MAPK3 | 0.11707294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.61471978 |
| 2 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 4.09346427 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.08261508 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.91648852 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.83469723 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.75873983 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.42450405 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.35182312 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.26791360 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.23659564 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.21534691 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.17538883 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.16153321 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.14314888 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.00373603 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.90366123 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.84574729 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.69823270 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.69738664 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.67130797 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.62528238 |
| 22 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.59822449 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.49713022 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.44423380 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.43822348 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35254339 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34073217 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.30931977 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.27396060 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.26937497 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.23863735 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.21191116 |
| 33 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.19734162 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14401990 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.14156907 |
| 36 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.12006937 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09819353 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.09762587 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.09420780 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.05919179 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.93098810 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92363277 |
| 43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.89149976 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 0.89071655 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 0.81766573 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 0.79386073 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.77339442 |
| 48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76334375 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.75040602 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 0.74730313 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 0.73888921 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72603543 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72026873 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 0.68664101 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65375344 |
| 56 | Pertussis_Homo sapiens_hsa05133 | 0.64457052 |
| 57 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63569846 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58045844 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.57294831 |
| 60 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57278085 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54178535 |
| 62 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52948412 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52934644 |
| 64 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.52924891 |
| 65 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.52685517 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48993628 |
| 67 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48116286 |
| 68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47568697 |
| 69 | Morphine addiction_Homo sapiens_hsa05032 | 0.45703489 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.44061133 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43691339 |
| 72 | Phototransduction_Homo sapiens_hsa04744 | 0.43555525 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43015696 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41902631 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.40576101 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.40220602 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39375052 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.38572911 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33874528 |
| 80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33419482 |
| 81 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.31557369 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30854017 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30139706 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29438678 |
| 85 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.29064981 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27711278 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.27589322 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24153987 |
| 89 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24145952 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.24087817 |
| 91 | Olfactory transduction_Homo sapiens_hsa04740 | 0.23498777 |
| 92 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.23459346 |
| 93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.22704769 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.21259759 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.20437108 |
| 96 | RNA degradation_Homo sapiens_hsa03018 | 0.19240525 |
| 97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.19049518 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.18555570 |
| 99 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.17128003 |
| 100 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.15271208 |

